A controlled study comparing visual function in patients treated with vigabatrin and tiagabine

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 3, 2003, Pages 339-343

  Krauss, G L ^a   Johnson, M A ^b   Sheth, S ^a   Miller, N R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLOR VISION; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTRORETINOGRAM; EPILEPSY; FEMALE; HUMAN; MALE; PERIMETRY; PRIORITY JOURNAL; VISION; VISUAL ACUITY; VISUAL FIELD;

ADULT; AGED; ANTICONVULSANTS; CROSS-SECTIONAL STUDIES; ELECTRORETINOGRAPHY; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; NIPECOTIC ACIDS; VIGABATRIN; VISUAL ACUITY; VISUAL FIELDS;

EID: 0037373430     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.3.339     Document Type: Article

References (25)

1. Krauss GL. Using the electroretinogram to detect and monitor the retinal toxicity of anticonvulsants. Neurology 2000;56:140-1.
2. Lawden MC, Eke T, Degg C, et al. Visual field defects associated with vigabatrin therapy. J Neurol Neurosurg Psychiatry 1999;67:716-22.
3. Johnson MA, Krauss GL, Miller NR, et al. Visual function loss from vigabatrin: effect of stopping the drug. Neurology 2000;55:40-5.
4. Miller NR. Using the electroretinogram to detect and monitor the retinal toxicity of anticonvulsants. Neurology 2000;55:333-4.
5. Coupland SG, Zackon DH, Leonard BC, et al. Vigabatrin effect on inner retinal function. Ophthalmology 2001;108:1493-8.
6. Ben Menachem E. Vigabatrin. Epilepsia 1995;36 (suppl 2):S95-104.
7. Meldrum BS. Update on the mechanism of action of antiepileptic drugs. Epilepsia 1996;37 (suppl 6):S4-11.
8. Meldrum BS, Chapman AG. Basic mechanisms of Gabritil (tiagabine) and future potential developments. Epilepsia 1999;40 (suppl 9):S2-6.
9. Beran RG, Hung A, Plunkett M, et al. Predictability of visual field defects in patients exposed to GABAergic agents, vigabatrin or tiagabine. Neurology 1999;52 (suppl 2):A249.
10. Kaufman KR, Lepore FE, Keyser BJ. Visual fields and tiagabine: a quandary. Seizure 2001;10:525-9.
11. Nousiainen I, Mantyjarvi M, Kalviainen R. Visual function in patients treated with GABAergic anticonvulsant drug tiagabine. Clinical Drug Investigation 2000;20:393-400.
12. Krauss GL, Miller NR. Vigabatrin: an effective antiepilepsy drug-balancing the risk of visual dysfunction. Ann Pharmacother 1999;33:1367-68.
13. Stefan H, Bernatik J, Knorr J. Visual field due to antiepileptic drugs. [In German]. Nervenarzt 1999;70:552-5.
14. Miller NR, Johnson MA, Paul SR, et al. Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings. Neurology 1999;106:1792-8.
15. Marmor MF, Arden GB, Nilsson SE, et al. Standard for clinical electroretinography. Arch Ophthalmol 1989;107:816-19.
16. Krauss GL, Johnson MA, Miller NR. Vigabatrin associated retinal cone system of dysfunction: electroretinogram and ophthalmologic findings. Neurology 1998;50:614-18.
17. Severns, ML, Johnson MA. Variability of the b-wave of the human ERG with intensity. Doc Ophthalmol 1993;85:291-9.
18. Paul SR, Krauss GL, Miller NR, et al. Visual function is stable in patients who continue long-term vigabatrin therapy: implications for clinical decision making. Epilepsia 2001;42:525-30.
19. Ravindran J, Blumbergs P, Crompton J, et al. Visual loss associated with vigabatrin: pathological correlations. J Neurol Neurosurg Psychiatry 2001;70:787-9.
20. Sills GJ, Butler E, Thompson GG, et al. Vigabatrin and tiagabine are pharmologically different drug. A pre-clinical study. Seizure 1999;8:404-11.
21. Fraser CM, Sills GJ, Butler E, et al. Effects of valproate, vigabatrin and tiagabine on GABA uptake into human astrocytes cultured from foetal and adult brain tissues. Epileptic Disord 1999;1:153-7.
22. Petroff OA, Hyder F, Collins T, et al. Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures. Epilepsia 1999;40:958-64.
23. Sills GJ, Patsalos PN, Butler E, et al. Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina. Neurology 2001;57:196-200.
24. Kuzniecky R, Ho S, Pan J, et al. Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology 2002;58:368-72.
25. 2+-independent excitatoxity neurodegeneration in osolated retina, an intact neural net: a role for Cl and inhibitory transmitters. Mol Pharmacol 1998;53:564-72.